AdComm backs Mesoblast cell therapy despite manufacturing concerns
Advisory committee votes in favor of Mesoblast’s allogeneic cell therapy despite questions about manufacturing consistency.
Advisory committee votes in favor of Mesoblast’s allogeneic cell therapy despite questions about manufacturing consistency.
European Union lines up deals to source up to 1.1 billion doses of three COVID-19 vaccines.
McKesson leverages existing link to US Centers for Disease Control and Prevention (CDC) to land $178 million COVID-19 vaccine.